Register entry

HEC Pharm USA Inc.

Data as of · How to read this entry

Registered sites
2
Active NDC listings
34
Labeller names
2
Live patents
0
Countries
2
Base
United States
Authorisation

Registered operations

Active ingredient (API) manufacture1Labelling1
Sites

Registered establishments

2
EstablishmentAddressRegistered forFEI / DUNS
HEC PHARM CO., LTD. The Second SiteRegistrant: HEC PHARM CO.,LTDNo. 3 Industrial Park of HEC, Yidu City, Yichang, Hubei Province 443300, China (CHN)Active ingredient (API) manufacture3006259537554546110
HEC Pharm USA Inc.101 Morgan Ln, Plainsboro, New Jersey (NJ) 08536, United States (USA)Labelling3016779715962953530
Catalogue

Drug listings by form and route

34

34 active NDC listings: 29 human prescription drug, 5 bulk ingredient. By marketing category: ANDA 29, BULK INGREDIENT 5.

Dosage formNDCs
tablet, film coated16
tablet8
powder5
tablet, orally disintegrating4
suspension1
RouteNDCs
oral29
Labeller name on the listingNDCs
hec pharm usa inc.29
hec pharm co., ltd5
Catalogue

Marketed products

34
BrandGeneric nameForm / routeNDC
-Azithromycin Dihydratepowder43781-0305BULK INGREDIENT
-Clarithromycinpowder43781-0403BULK INGREDIENT
-Erythromycinpowder43781-2103BULK INGREDIENT
-Erythromycin Thiocyanatepowder43781-2202BULK INGREDIENT
FEBUXOSTATfebuxostattablet, oral72303-0855ANDA
FEBUXOSTATfebuxostattablet, oral72303-0856ANDA
-Lincomycin Hydrochloridepowder43781-2301BULK INGREDIENT
OLANZAPINEOlanzapinetablet, oral72303-0835ANDA
OLANZAPINEOlanzapinetablet, oral72303-0836ANDA
OLANZAPINEOlanzapinetablet, oral72303-0837ANDA
OLANZAPINEOlanzapinetablet, oral72303-0838ANDA
OLANZAPINEOlanzapinetablet, oral72303-0839ANDA
OLANZAPINEOlanzapinetablet, oral72303-0840ANDA
OLMESARTAN MEDOXOMILOlmesartan medoxomiltablet, film coated, oral72303-0848ANDA
OLMESARTAN MEDOXOMILOlmesartan medoxomiltablet, film coated, oral72303-0849ANDA
OLMESARTAN MEDOXOMILOlmesartan medoxomiltablet, film coated, oral72303-0850ANDA
OlanzapineOlanzapinetablet, orally disintegrating, oral72303-0841ANDA
OlanzapineOlanzapinetablet, orally disintegrating, oral72303-0842ANDA
OlanzapineOlanzapinetablet, orally disintegrating, oral72303-0843ANDA
OlanzapineOlanzapinetablet, orally disintegrating, oral72303-0844ANDA
Oseltamivir Phosphateoseltamivir phosphatesuspension, oral72303-0851ANDA
Rosuvastatin calciumRosuvastatin calciumtablet, film coated, oral72303-0827ANDA
Rosuvastatin calciumRosuvastatin calciumtablet, film coated, oral72303-0828ANDA
Rosuvastatin calciumRosuvastatin calciumtablet, film coated, oral72303-0829ANDA
Rosuvastatin calciumRosuvastatin calciumtablet, film coated, oral72303-0830ANDA
SildenafilSildenafiltablet, film coated, oral72303-0845ANDA
SildenafilSildenafiltablet, film coated, oral72303-0846ANDA
SildenafilSildenafiltablet, film coated, oral72303-0847ANDA
Solifenacin succinatesolifenacin succinatetablet, film coated, oral72303-0831ANDA
Solifenacin succinatesolifenacin succinatetablet, film coated, oral72303-0832ANDA
TADALAFILTadalafiltablet, film coated, oral72303-0822ANDA
TADALAFILTadalafiltablet, film coated, oral72303-0823ANDA
TADALAFILTadalafiltablet, film coated, oral72303-0824ANDA
TADALAFILTadalafiltablet, film coated, oral72303-0825ANDA
Neighbours

Registered in the same town

5
Compare

Comparable companies in United States

Enquiry

Common questions

Is HEC Pharm USA Inc. FDA approved?
HEC Pharm USA Inc. holds 2 FDA-registered establishments across 2 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are HEC Pharm USA Inc.'s drugs manufactured?
At registered sites in China, the United States. The FDA register lists Yichang; Plainsboro, NJ. Registered operations: active ingredient (API) manufacture, labelling.
What drugs does HEC Pharm USA Inc. make?
34 products are listed under HEC Pharm USA Inc. in the openFDA NDC Directory, most often as tablet, film coated; tablet; powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.